vimarsana.com

Page 2 - துறை ஆஃப் மருத்துவ ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Global Virus Network Analysis Suggests Measles, Polio and Tuberculosis Vaccines May Boost Immunity to Coronavirus

Global Virus Network Analysis Suggests Measles, Polio and Tuberculosis Vaccines May Boost Immunity to Coronavirus Innate Immunity Created by Live Attenuated Vaccines Like Measles and Polio May Provide Some Protection Against Future Pandemics - Idea Needs To Be Tested, Scientists Say News provided by Share this article Share this article BALTIMORE, May 18, 2021 /PRNewswire/ Members of the Global Virus Network (GVN), a coalition comprised of human and animal virologists from 63 Centers of Excellence and 11 Affiliates in 35 countries, and colleagues today published a perspective proposing that live attenuated vaccines (LAVs), such as those for tuberculosis, measles, and polio, may induce protective innate immunity that mitigate other infectious diseases, triggering the human body s natural emergency response to infections including COVID-19 as well as future pandemic threats. 

Know the scientist: Charles Herbert Best

He was among the first to introduce anticoagulants in the treatment of blood clots. (Subscribe to Science For All, our weekly newsletter, where we aim to take the jargon out of science and put the fun in. Click here.) Charles Herbert Best (1899 – 1978) was an American-Canadian scientist, who co-discovered insulin, a critical milestone in the treatment of diabetes. Charles Best also discovered the vitamin choline and the enzyme histaminase. He was among the first to introduce anticoagulants in the treatment of blood clots. Best was born in Maine, the U.S., in 1899. He grew up in Pembroke before joining the University of Toronto, Toronto, Canada, to study medicine in 1915, but his studies were interrupted by the onset of the First World War. He served as an infantry soldier and later as an acting Sergeant Major in the Canadian Army. He returned to Toronto in 1921 to continue his studies. He was a professional basketball player and used his remuneration from sports to pay his aca

Study finds Saliva-based Covid-19 test to be safe, quick and economical

Updated: Mar 5, 2021, 09:09 PM IST An eight-month-long study to determine the feasibility of the Saliva-based Covid-19 Rapid Antigen Test (RAT) has revealed that the test is less expensive, faster and safer than the RT-PCR tests which are widely used in India. While saliva-based RAT is approved by the Food and Drug Administration (FDA) in the US, this test is not approved by the Indian Council of Medical Research (ICMR). However, nasal and oral RAT is permitted in India.  According to the doctors, this study was done to establish the efficacy of the test among the Indian population, as not many studies were performed in India on this method of saliva-based testing. 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.